Información del producto
LDC7559 is a reactive oxygen species-dependent compound that has been found to be cytotoxic against cancer cells. It induces cell lysis by oxidative damage, causing the release of cytoplasmic contents into the extracellular space. This compound also inhibits the production of inflammatory compounds such as prostaglandins, leukotrienes, and cytokines. LDC7559 is currently in phase II clinical trials for treating inflammatory bowel disease and experimental colitis. LDC7559 has also shown anti-inflammatory properties in vitro and in vivo models of autoimmune diseases such as asthma, arthritis, psoriasis, and Crohn's disease.
Propiedades químicas
Consulta técnica sobre: 3D-HWD78201 LDC7559
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.